Plasminogen activator inhibitor 1 (PAI-1) 4G/5G polymorphism-994
Test info
Gene polymorphism
PAI-1 4G/5G Polymorphism
Deep vein thrombosis (DVT) and coronary artery disease (CAD) are associated with increased PAI-1 levels. Elevated PAI-1 levels may help predict risk of reinfarction in survivors of myocardial infarction, particularly in young individuals. PAI-1 levels tend to be lower in individuals with 4G/5G or 5G/5G genotype compared to a 4G/4G genotype.
Specimen
Immediately following collection, mix sample thoroughly by gently inverting 8 - 10 times to prevent clotting
Lavender (EDTA), 4mL
Yellow ACD (A or B)
Immediately following collection, mix sample thoroughly by gently inverting 8 - 10 times to prevent clotting
Yellow ACD (A or B)
Molecular Medicare Billing Request
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.
Ambient (preferred) - 8 days
Refrigerated - 8 days
Performance
Polymerase Chain Reaction (PCR) and Restriction Fragment Length Polymorphism (RFLP) technologies
Clinical and Interpretive info
An interpretive report will be provided
Billing
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.